ZDHHC3 and metabolic dysfunction-associated steatohepatitis: In animal models with NASH, ZDHHC3 performed acceleration of pro‐inflammation, steatosis, and early fibrosis formation by increasing S‐palmitoylation‐stabilized IRHOM2 along with decrease in proteasome degradation of IRHOM2.